The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1
1Department of Molecular Genetics, University of Illinois College of Medicine, Chicago, Illinois 60607, USA.
Abstract:
CDC25A phosphatase promotes cell cycle progression by activating G(1) cyclin-dependent kinases and has been postulated to be an oncogene because of its ability to cooperate with RAS to transform rodent fibroblasts. In this study, we have identified apoptosis signal-regulating kinase 1 (ASK1) as a CDC25A-interacting protein by yeast two-hybrid screening. ASK1 activates the p38 mitogen-activated protein kinase (MAPK) and c-Jun NH(2)-terminal protein kinase-stress-activated protein kinase (JNK/SAPK) pathways upon various cellular stresses. Coimmunoprecipitation studies demonstrated that CDC25A physically associates with ASK1 in mammalian cells, and immunocytochemistry with confocal laser-scanning microscopy showed that these two proteins colocalize in the cytoplasm. The carboxyl terminus of CDC25A binds to a domain of ASK1 adjacent to its kinase domain and inhibits the kinase activity of ASK1, independent of and without effect on the phosphatase activity of CDC25A. This inhibitory action of CDC25A on ASK1 activity involves diminished homo-oligomerization of ASK1. Increased cellular expression of wild-type or phosphatase-inactive CDC25A from inducible transgenes suppresses oxidant-dependent activation of ASK1, p38, and JNK1 and reduces specific sensitivity to cell death triggered by oxidative stress, but not other apoptotic stimuli. Thus, increased expression of CDC25A, frequently observed in human cancers, could contribute to reduced cellular responsiveness to oxidative stress under mitogenic or oncogenic conditions, while it promotes cell cycle progression. These observations propose a mechanism of oncogenic transformation by the dual function of CDC25A on cell cycle progression and stress responses.
Insights
CDC25A phosphatase interacts with apoptosis signal-regulating kinase 1 (ASK1), inhibiting its activity. This dual function promotes cell cycle progression and reduces oxidative stress sensitivity, contributing to cancer development.
Area of Science:
- Cellular Biology
- Molecular Oncology
- Signal Transduction
Background:
- CDC25A phosphatase is known to promote cell cycle progression and is implicated as an oncogene.
- Apoptosis signal-regulating kinase 1 (ASK1) is activated by cellular stresses and regulates MAPK and JNK/SAPK pathways.
Purpose of the Study:
- To identify proteins interacting with CDC25A.
- To elucidate the functional consequences of CDC25A and ASK1 interaction on cellular stress responses and cell cycle progression.
Main Methods:
- Yeast two-hybrid screening to identify CDC25A-interacting proteins.
- Coimmunoprecipitation and confocal microscopy to confirm protein association and localization.
- Inducible transgene expression to study the effects of CDC25A on ASK1 signaling and cell death.
Main Results:
- Apoptosis signal-regulating kinase 1 (ASK1) was identified as a CDC25A-interacting protein.
- CDC25A physically associates with ASK1 in the cytoplasm and inhibits ASK1 kinase activity by reducing its homo-oligomerization.
- Increased CDC25A expression suppressed oxidant-dependent activation of ASK1, p38, and JNK1, reducing sensitivity to oxidative stress-induced cell death.
Conclusions:
- CDC25A possesses a dual function: promoting cell cycle progression and inhibiting stress-activated signaling pathways.
- CDC25A's inhibition of ASK1 contributes to reduced cellular responsiveness to oxidative stress, potentially aiding oncogenic transformation.
- The interaction between CDC25A and ASK1 provides a novel mechanism linking cell cycle control and stress response evasion in cancer.
Related Concept Videos
Inhibition of Cdk Activity
Anaphase Promoting Complex
DNA Damage Can Stall the Cell Cycle
MAPK Signaling Cascades
Inhibition of CDK Activity
Anaphase Promoting Complex


